Pediatrician Visits - Pain Free
Dreading another
doctor appointment with your little one??
Well LAPregnancy
found out about a miracle cream that takes away the pain from all of
those shots!
That's right, EMLA is
a unique product that numbs your child's skin at the injection site
and makes needle insertions and other procedures less painful. EMLA
can easily be applied at home - just ask your doctor for a
prescription and get to your pharmacist today!
THE DETAILS:
Applying EMLA
EMLA Cream should be applied 1 hour before the shot or needle
procedure. Satisfactory numbing of the skin occurs 1 hour after
application, reaches a maximum at 2 to 3 hours (1 hour for children
less than 3 months), and lasts for 1 to 2 hours after removal. This
timing makes it convenient to apply EMLA at home prior to
appointment.
Who can use EMLA?
EMLA can be used for most children, including infants at least 37
weeks gestation. However, it should not be used in children with
rare condition of congenital or idiopathic methemoglobinemia, or in
infants under the age of 12 months who are receiving treatment with
methemoglobin-inducing agents. It should also not be used in
children with sensitivity to lidocaine or prilocaine, or any other
component of the product. If you have any questions as to whether or
not EMLA is right for your child, please consult your child's
doctor.
Accidental ingestion
of EMLA may be toxic. Call your local Poison Control Center and your
doctor.
EMLA Cream (lidocaine
2.5% and prilocaine 2.5%) is indicated as topical anesthetics for
use on normal intact skin for local analgesia (pain relief). EMLA is
contraindicated in patients with a known history of sensitivity to
local anesthetics of the amide type or any other component of the
product. EMLA is indicated for genital mucous membranes for
superficial minor surgery and as pretreatment for infiltration
anesthesia. EMLA can be used on infants with a gestational age of 37
weeks or more. If EMLA is left on the skin for longer times or
applied over larger skin areas than recommended by a physician,
serious side effects, such as methemoglobinemia, may occur. In
patients treated with EMLA in clinical studies, the percentage of
patients in which local effects at the application site were
observed included: skin paleness (pallor or blanching) 37%, redness
30%, a changed ability to feel hot or cold 7%, swelling 6%, itching
2%, and rash, less than 1%. These mild side effects generally went
away by themselves within 1 or 2 hours. |